Long COVID
- Submission status
- Closed
- Submission deadline
Infection with the SARS CoV-2 virus can lead to symptoms that persist for weeks, months, or even years after the acute phase of infection has passed. These symptoms may include fatigue, shortness of breath, difficulty concentrating, loss of taste and smell, heart palpitations, headache, and muscle pain, among others. While estimates vary on the prevalence of long COVID – also known as post-COVID, long-haul COVID, chronic COVID, post-acute COVID-19, and post-acute sequelae COVID-19, or PASC – it is increasingly clear that a substantial proportion of COVID-19 survivors will experience at least one lingering COVID-related symptom. The mechanisms underlying this phenomenon are poorly understood; leading hypotheses include a prolonged inflammatory response, the triggering of autoimmunity, and the presence of viral reservoirs in the body.
This Collection invites research on the causes, risk factors, and frequency of long COVID, as well as on the development of diagnostic tools and treatments.
Editors
-
Nicolas G. Bazan
LSU Health New Orleans, USA
-
Artur Fedorowski
Karolinska University Hospital, Sweden; Karolinska Institute, Sweden
-
Seyed Ehtesham Hasnain
Indian Institute of Technology, India; Sharda University, India
-
Roxana Moslehi
University at Albany - State University of New York, USA
-
Annette Regan
University of San Francisco, USA
Nicolas G. Bazan is Founding Director of the Neuroscience Center of Excellence at LSU Health New Orleans. His team uncovered lipid mediators that reduce the ability of the SARS-CoV-2 Spike (S) protein to bind to receptors and enter human lung cells. He is defining new signaling and neuroprotective mechanisms in Long COVID. Dr. Bazan has been an Editorial Board Member for Scientific Reports since 2022.
Artur Fedorowski is a Senior Consultant at Karolinska University Hospital and an Associate Professor at the Karolinska Institute. His research areas include: syncope, orthostatic hypotension, cardiac arrhythmias, cardiovascular autonomic dysfunction, hypertension, biomarkers and cardiovascular diseases. Dr. Fedorowski has been an Editorial Board Member for Scientific Reports since 2022.
Seyed Hasnain is a National Science Chair at Indian Institute of Technology and Distinguished Professor at Sharda University. His research focuses on infection biology and functional molecular epidemiology of infectious pathogens such as Mycobacterium tuberculosis. He has also been involved in understanding the molecular evolution of SARS-CoV-2. Professor Hasnain has been an Editorial Board Member for Scientific Reports since 2019.
Roxana Moslehi is an Associate Professor and Genetic Epidemiologist in the School of Public Health at University at Albany, State University of New York. Her research aims to identify genetic and environmental determinants of complex disorders. One of her current projects involves research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to better understand the illness, including its molecular epidemiologic link to cancer, auto-immune disease, and long-haul COVID-19. Dr. Moslehi has been an Editorial Board Member for Scientific Reports since 2022.
Annette Regan is an Assistant Professor in the School of Nursing and Health Professions at University of San Francisco. As an infectious disease epidemiologist, her research focuses on the use of real-world data to document the burden of respiratory virus infections and the health effects of vaccine programs. Dr. Regan has been an Editorial Board Member for Scientific Reports since 2022.
